The phenotype of macrophages which are not transformed into foam cells in atherogenesis

Atherosclerosis

Volumn 121, Issue 2, 1996, Pages 245-251

  Nagornev, Vladimir A ^a   Maltseva, Svetlana V ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Russian Federation)

Author keywords

Atherogenesis; Cytokines; Macrophage phenotype; Macrophage proliferation

Indexed keywords

CYTOKINE; RECOMBINANT INTERLEUKIN 1BETA;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; AUTOPSY; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; FOAM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; MACROPHAGE; PHENOTYPE; PRIORITY JOURNAL;

EID: 0029962936     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(95)05726-9     Document Type: Article

References (17)

1. Klimov AN, Nagornev VA, Denisenko AD. Immunoreactivity and atherosclerosis. Soc Med Rev A Cardiol 1987;1:337.
2. Klimov AN. On the participation of lipoprotein-antibody immune complexes in atherogenesis. Angeiologie 1991;43:95.
3. Parums DV, Brown DL, Mitchinson MJ. Serum antibodies to oxidized low density lipoprotein and ceroid in chronic periaortitis. Arch Pathol Lab Med 1990;114:46.
4. Yla-Herttuala S, Butler S, Picard S, Palinski W, Steinberg D, Witztum JL. Rabbit and human atherosclerotic lesions contain IgG that recognizes MDA-LDL and coperoxidized LDL. Arteriosclerosis 1991;11:1426 (abstract).
5. Salonen JT, Yla-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssonen K, Palinsky W, Witztum JL. Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet 1992;339:883.
6. Nagornev VA. Morphologic and pathogenetic aspects of coronary artery atherosclerosis in ischemic heart disease. Zentralbl Allg Pathol Pathol Anat 1989;135:591.
7. Gown AM, Tsukada T, Ross R. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol 1986;125:191.
8. Emeson EE, Robertson AL. T-lymphocytes in aortic and coronary intimas. Their potential role in atherogenesis. Am J Pathol 1988;130:369.
9. Hansson GK, Jonasson L, Seifert PS. Immune mechanisms in atherosclerosis. Arteriosclerosis 1989;9:567.
10. Clinton SK, Libby P. Cytokines and growth factors in atherogenesis. Arch Pathol Lab Med 1992;116:1292.
11. Ettinger WH, Miller LA, Smith TK, Parks JS. Effect of interleukin-1 alpha on lipoprotein lipids in cynomolgus monkeys: Comparison to tumor necrosis factor. Biochem Biophys Acta 1992;1128:186.
12. Simbirtsev A, Prokopieva E, Ivanova E, Konusova V, Perumov N, Ketlinsky S. Interleukin-1 and tumor necrosis factor production by human monocytoid cells: study on a single cell level. Eur Cytokine Netw 1992;3:421.
13. McMillan BC, Duff G. Mitotic activity in the aortic of experimental cholesterol atherosclerosis of rabbits. Arch Pathol 1949;46:179.
14. Ku S, Thomas CE, Jackson RL. Regulation of interleukin I expression by modified lipoproteins: A unified cytokine hypothesis for the pathogenesis of atherosclerosis. In: Stein O, Eisenberg S, Stein Y. (eds.), Atherosclerosis IX, Proc. 9th Int. Symp. on Atherosclerosis, R.a.L., Tel Aviv: Creative Communications Ltd., 1992;359.
15. Brown MS, Goldstein JL. The LDL receptor concept: Clinical and therapeutic implications. Atheroscler Rev 1988;18:85.
16. Mahley RW. Development of accelerated atherosclerosis. Concepts derived from cell biology and animal model studies. Arch Pathol Lab Med 1983;107:393.
17. Spagnoli LS, Orlandi A, Santeusanio S. Foam cells of the rabbit atherosclerotic plaque arrested in metaphase by colchicine show a macrophage phenotype. Atherosclerosis 1991;88:87.